Publications

cemka > Publications

Sort publications on year

  • Pharmaco-Economics

    IntĂ©rĂȘt des bases de remboursement de l’Assurance maladie pour l’analyse de la prise en charge des maladies chroniques : le cas de l’épilepsie

    FAGNANI F, VESPIGNANI H, KUSNIK-JOINVILLE O, BERTRAND M, MURAT C, LEVY-BACHELOT L, KAHANE P

    Presse Med ; 2013;42:285-292

  • Pharmaco-Economics

    Incidence and costs of bleeding-related complications in French hospitals following surgery for various diagnoses

    YE X, LAFUMA A, TORRETON E, ARNAUD A

    BMC Health Serv Res ; 2013;13(1):186

  • Pharmaco - Epidemiology

    Hereditary angioedema with C1 inhibitor deficiency : clinical presentation and quality of life of 193 French patients

    BOUILLET L, DAVID LAUNAY D, FAIN O, BOCCON-GIBOD I, LAURENT J, MARTIN L, MONTAUBAN V, FINCK K, BOUÉE S, GOMPEL A, KANNY G

    Ann Allergy Asthma Immunol ; 2013;111:290-294

  • Pharmaco - Epidemiology

    Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross Sectional Study

    GRANDFILS N, DETOURNAY B, ATTALI C, JOLY D, SIMON D, VERGES B, TOUSSI M, BRIAND Y, DELAITRE O

    Int J Endocrinol ; 2013;2013:640632

  • Pharmaco - Epidemiology

    Facteurs associĂ©s Ă  l’hospitalisation des personnes diabĂ©tiques adultes en France Entred 2007

    ASSOGBA F , PENFORNIS F , DETOURNAY B, LECOMTE  P, BOURDEL-MARCHASSON I, DRUET C , WEILL A , FAGOT-CAMPAGNA A, FOSSE-EDORH S

    BEH ; 2013;37-38:454-463

  • Pharmaco - Epidemiology

    Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof(Âź) SN60WF, Akreos(Âź) AO-MI60 and Hoya(Âź) YA-60BB

    BOURDIOL DUCASSE AM, GUERZIDER V, VELASQUE L, DOMINGUEZ M, LAFUMA A, ROBERT J

    J Fr Ophtalmol ; 2013;36:575-582

  • Pharmaco-Economics

    Aspects Ă©conomiques du diabĂšte en France : quelles Ă©volutions?

    DETOURNAY B

    Med Mal Metab ; 2013;7(3):224-227

  • Pharmaco - Epidemiology

    Use of vildagliptin in management of type 2 diabetes : effectiveness, treatment persistence and safety from the 2-year real-life VILDA study

    SIMON D, DETOURNAY B, ESCHWEGE E, BOUEE S, BRINGER J, ATTALI C, DEJAGER S

    Diabetes Ther ; 2014;5(1):207-224

  • Pharmaco - Epidemiology

    Types 2 diabetes prevalence, health status and quality of care among the North African immigrant population living in France

    FOSSE-EDORH S, FAGOT-CAMPANA A, DETOURNAY B, BIHAN H, GAUTIER A, DALICHAMPT M, DRUET C

    Diabetes Metab ; 2014;40(2):143-50

  • Pharmaco - Epidemiology

    Management of focal epilepsy in adults treated with polytherapy in France : The direct cost of drug resistance (ESPERA study)

    DE ZÉLICOURT M, DE TOFFOL B, VESPIGNANI H, LAURENDEAU C, LÉVY-BACHELOT L, MURAT C, FAGNANI F

    Seizure ; 2014;23(5):349-356

  • Pharmaco-Economics

    L’évaluation Ă©conomique dans le champ de la santĂ©

    DETOURNAY B

    MĂ©decine/Sciences ; 2014;30(5):584-587

  • Pharmaco - Epidemiology

    Adjustment disorder with anxiety in old age: Comparing prevalence and clinical management in primary care and mental health care

    ARBUS C, HERGUETA T, DUBURCQ A, SALEH A, LE GUERN M-E, ROBERT P, CAMUS V

    Eur Psychiatry ; 2014;29:233-238

  • Pharmaco - Epidemiology

    [Adult patients treated for focal epilepsy with antiepileptic drugs (AEDs) in combination in France: Description according to the 2009 ILAE definition of AED resistance (ESPERA study)]

    VESPIGNANI H, DE ZÉLICOURT M, LAURENDEAU C, FAGNANI F, LEVY-BACHELOT L, MURAT C, KAHANE P, DE TOFFOL B

    Rev Neurol ; 2014;170(2): 100-109